Skip to main content
. Author manuscript; available in PMC: 2013 Jul 3.
Published in final edited form as: J Nucl Med. 2012 May 10;53(6):961–968. doi: 10.2967/jnumed.111.092361

Figure 2.

Figure 2

64Cu–histidine handling. (A) 64Cu–histidine clearance from blood in LEC+/−, LEC−/−, and LEA rats. (B) Uptake of 64Cu–histidine in liver and other organs. (C) Bile 64Cu excretion in LEA, LEC+/−, and LEC−/− rats. (D) 64Cu excretion in bile as percentage of liver plus bile activity. (E) 64Cu activity in organs 1, 3, and 24 h after 64Cu–histidine was given. Asterisks indicate P < 0.05 vs. LEA and LEC+/− rats. *P < 0.05, ANOVA.